Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment

dc.contributor.authorQueiroz-Telles, Flavio
dc.contributor.authorNucci, Marcio
dc.contributor.authorColombo, Arnaldo Lopes [UNIFESP]
dc.contributor.authorTobon, Angela
dc.contributor.authorRestrepo, Angela
dc.contributor.institutionUniv Fed Parana
dc.contributor.institutionUniversidade Federal do Rio de Janeiro (UFRJ)
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionCorp Invest Biol
dc.date.accessioned2016-01-24T14:06:20Z
dc.date.available2016-01-24T14:06:20Z
dc.date.issued2011-04-01
dc.description.abstractImplantation or subcutaneous mycoses are a frequent health problem in Latin American countries and other tropical and subtropical areas. Although such infections rarely cause disseminated or invasive disease, they have an important impact on public health, and timely diagnosis and appropriate treatment remain important. Although some implantation mycoses are found in immunocompromised persons, the immunocompetent population is the principal target in Latin America. Most etiologic agents are found in soil, vegetation, and decaying matter in tropical, subtropical, and humid environments and infection is commonly the result of penetrating injury. Infections primarily occur (1) among low socioeconomic groups, (2) among those living in rural areas or involved in farming, hunting, or other outdoor activities, and (3) particularly among adult men. This review focuses on the epidemiology of the most clinically significant implantation mycoses in Latin America, i.e., sporotrichosis, eumycetoma, chromoblastomycosis, subcutaneous phaeohyphomycosis, subcutaneous zygomycosis, and lacaziosis. Main epidemiologic findings, clinical manifestations, diagnosis, and treatment options are also discussed.en
dc.description.affiliationUniv Fed Parana, Hosp Clin, Infect Dis Unit, Div Infect Dis,Dept Publ Hlth, BR-8006090 Curitiba, Parana, Brazil
dc.description.affiliationUniv Fed Rio de Janeiro, Univ Hosp, Rio de Janeiro, Brazil
dc.description.affiliationEscola Paulista Med, Dept Med, Div Infect Dis, BR-04023 São Paulo, Brazil
dc.description.affiliationCorp Invest Biol, Medellin, Colombia
dc.description.affiliationUnifespEscola Paulista Med, Dept Med, Div Infect Dis, BR-04023 São Paulo, Brazil
dc.description.sourceWeb of Science
dc.description.sponsorshipSchering-Plough
dc.description.sponsorshipMerck Co., Inc.
dc.description.sponsorshipAstellas
dc.description.sponsorshipJanssen
dc.description.sponsorshipMerck
dc.description.sponsorshipPfizer
dc.description.sponsorshipUnited Medical
dc.format.extent225-236
dc.identifierhttp://dx.doi.org/10.3109/13693786.2010.539631
dc.identifier.citationMedical Mycology. London: Informa Healthcare, v. 49, n. 3, p. 225-236, 2011.
dc.identifier.doi10.3109/13693786.2010.539631
dc.identifier.issn1369-3786
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/33582
dc.identifier.wosWOS:000288323400001
dc.language.isoeng
dc.publisherInforma Healthcare
dc.relation.ispartofMedical Mycology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.licensehttp://informahealthcare.com/userimages/ContentEditor/1255620309227/Copyright_And_Permissions.pdf
dc.subjectsubcutaneous mycosesen
dc.subjectendemic mycosesen
dc.subjectposaconazoleen
dc.subjectitraconazoleen
dc.titleMycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatmenten
dc.typeinfo:eu-repo/semantics/article
Arquivos